Juan Liu

机构：Fudan University, Zhongshan Hospital, Huangshi Central Hospital · ORCID：0009-0007-2878-044X

发表论文 153 篇 · 总被引 9078 次 · h-index 35

代表论文

• A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy (2025 · Nature Communications · 被引 81)
• Cellular spermine targets JAK signaling to restrain cytokine-mediated autoimmunity (2024 · Immunity · 被引 62)
• Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma (2023 · Journal of Experimental & Clinical Cancer Research · 被引 38)
• Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy (2023 · Science China Life Sciences · 被引 35)
• Methyltransferase Setd2 prevents T cell–mediated autoimmune diseases via phospholipid remodeling (2024 · Proceedings of the National Academy of Sciences · 被引 34)
• A pH-dependent anti-CD47 antibody that selectively targets solid tumors and improves therapeutic efficacy and safety (2023 · Journal of Hematology & Oncology · 被引 31)